Connection

Murray Passo to Female

This is a "connection" page, showing publications Murray Passo has written about Female.
Connection Strength

0.260
  1. Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus. Lupus. 2006; 15(4):198-206.
    View in: PubMed
    Score: 0.014
  2. Improving rheumatologists' screening for alcohol use and sexual activity. Arch Pediatr Adolesc Med. 2000 May; 154(5):478-83.
    View in: PubMed
    Score: 0.009
  3. Serum S100A8/A9 and S100A12 Levels in Children With Polyarticular Forms of Juvenile Idiopathic Arthritis: Relationship to Maintenance of Clinically Inactive Disease During Anti-Tumor Necrosis Factor Therapy and Occurrence of Disease Flare After Discontinuation of Therapy. Arthritis Rheumatol. 2019 03; 71(3):451-459.
    View in: PubMed
    Score: 0.009
  4. The relationship of hepatotoxic risk factors and liver histology in methotrexate therapy for juvenile rheumatoid arthritis. J Pediatr. 1999 Jan; 134(1):47-52.
    View in: PubMed
    Score: 0.008
  5. Use of methotrexate in children. Bull Rheum Dis. 1998 Aug; 47(5):1-5.
    View in: PubMed
    Score: 0.008
  6. Risk, Timing, and Predictors of Disease Flare After Discontinuation of Anti-Tumor Necrosis Factor Therapy in?Children With Polyarticular Forms of Juvenile Idiopathic?Arthritis With Clinically Inactive Disease. Arthritis Rheumatol. 2018 09; 70(9):1508-1518.
    View in: PubMed
    Score: 0.008
  7. High Levels of DEK Autoantibodies in Sera of Patients With Polyarticular Juvenile Idiopathic Arthritis and With Early Disease Flares Following Cessation of Anti-Tumor Necrosis Factor Therapy. Arthritis Rheumatol. 2018 04; 70(4):594-605.
    View in: PubMed
    Score: 0.008
  8. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis. Arthritis Rheum. 1997 Dec; 40(12):2226-34.
    View in: PubMed
    Score: 0.008
  9. Biologic therapies for refractory juvenile dermatomyositis: five years of experience of the Childhood Arthritis and Rheumatology Research Alliance in North America. Pediatr Rheumatol Online J. 2017 Jun 13; 15(1):50.
    View in: PubMed
    Score: 0.008
  10. Systemic cat-scratch disease presenting as leukocytoclastic vasculitis. Pediatr Infect Dis J. 1996 Jan; 15(1):93-5.
    View in: PubMed
    Score: 0.007
  11. Identifying treatment responders and predictors of improvement after cognitive-behavioral therapy for juvenile fibromyalgia. Pain. 2014 Jul; 155(7):1206-1212.
    View in: PubMed
    Score: 0.006
  12. MRI findings of lipoma arborescens of the knee in a child: case report. Pediatr Radiol. 1994; 24(4):258-9.
    View in: PubMed
    Score: 0.006
  13. Utility of the PedsQL rheumatology module as an outcome measure in juvenile fibromyalgia. Arthritis Care Res (Hoboken). 2013 Nov; 65(11):1820-7.
    View in: PubMed
    Score: 0.006
  14. Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 May; 65(5):745-52.
    View in: PubMed
    Score: 0.006
  15. Changes in pain coping, catastrophizing, and coping efficacy after cognitive-behavioral therapy in children and adolescents with juvenile fibromyalgia. J Pain. 2013 May; 14(5):492-501.
    View in: PubMed
    Score: 0.006
  16. Cognitive behavioral therapy for the treatment of juvenile fibromyalgia: a multisite, single-blind, randomized, controlled clinical trial. Arthritis Rheum. 2012 Jan; 64(1):297-305.
    View in: PubMed
    Score: 0.005
  17. Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011 Nov; 63(11):1511-6.
    View in: PubMed
    Score: 0.005
  18. Controlled follow-up study of physical and psychosocial functioning of adolescents with juvenile primary fibromyalgia syndrome. Rheumatology (Oxford). 2010 Nov; 49(11):2204-9.
    View in: PubMed
    Score: 0.005
  19. Actigraphy-based physical activity monitoring in adolescents with juvenile primary fibromyalgia syndrome. J Pain. 2010 Sep; 11(9):885-93.
    View in: PubMed
    Score: 0.005
  20. Relationship between school absenteeism and depressive symptoms among adolescents with juvenile fibromyalgia. J Pediatr Psychol. 2010 Oct; 35(9):996-1004.
    View in: PubMed
    Score: 0.005
  21. Neutrophil gelatinase-associated lipocalin is a predictor of the course of global and renal childhood-onset systemic lupus erythematosus disease activity. Arthritis Rheum. 2009 Sep; 60(9):2772-81.
    View in: PubMed
    Score: 0.004
  22. Educational and occupational outcomes among young adults with juvenile idiopathic arthritis. Arthritis Rheum. 2008 Oct 15; 59(10):1385-91.
    View in: PubMed
    Score: 0.004
  23. Anxiety, mood, and behavioral disorders among pediatric patients with juvenile fibromyalgia syndrome. Clin J Pain. 2008 Sep; 24(7):620-6.
    View in: PubMed
    Score: 0.004
  24. Adherence to medications in systemic lupus erythematosus. J Clin Rheumatol. 2008 Aug; 14(4):195-201.
    View in: PubMed
    Score: 0.004
  25. Incomplete Kawasaki disease with facial nerve paralysis and coronary artery involvement. Pediatr Infect Dis J. 1988 Apr; 7(4):301-2.
    View in: PubMed
    Score: 0.004
  26. Neutrophil gelatinase-associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol. 2008 Mar; 23(3):403-12.
    View in: PubMed
    Score: 0.004
  27. Initial validation of the Pediatric Automated Neuropsychological Assessment Metrics for childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2007 Oct 15; 57(7):1174-82.
    View in: PubMed
    Score: 0.004
  28. Identification of a urinary proteomic signature for lupus nephritis in children. Pediatr Nephrol. 2007 Dec; 22(12):2047-57.
    View in: PubMed
    Score: 0.004
  29. Effectively measuring adherence to medications for systemic lupus erythematosus in a clinical setting. Arthritis Rheum. 2007 Aug 15; 57(6):1000-6.
    View in: PubMed
    Score: 0.004
  30. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum. 2007 Mar; 56(3):965-71.
    View in: PubMed
    Score: 0.004
  31. Urinary neutrophil gelatinase-associated lipocalin as a biomarker of nephritis in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 2006 Aug; 54(8):2577-84.
    View in: PubMed
    Score: 0.004
  32. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis Rheum. 2006 Jul; 54(7):2235-42.
    View in: PubMed
    Score: 0.004
  33. What more can we learn from muscle histopathology in children with dermatomyositis/polymyositis? Clin Exp Rheumatol. 2006 May-Jun; 24(3):333-43.
    View in: PubMed
    Score: 0.004
  34. Arthritis associated with inflammatory bowel disease in children. Relationship of joint disease to activity and severity of bowel lesion. Dig Dis Sci. 1986 May; 31(5):492-7.
    View in: PubMed
    Score: 0.004
  35. Muscle metabolites, detected in urine by proton spectroscopy, correlate with disease damage in juvenile idiopathic inflammatory myopathies. Arthritis Rheum. 2005 Aug 15; 53(4):565-70.
    View in: PubMed
    Score: 0.003
  36. Gastrointestinal symptoms and their association with health-related quality of life of children with juvenile rheumatoid arthritis: validation of a gastrointestinal symptom questionnaire. J Clin Rheumatol. 2005 Aug; 11(4):194-204.
    View in: PubMed
    Score: 0.003
  37. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum. 2005 Jan; 52(1):239-46.
    View in: PubMed
    Score: 0.003
  38. Lack of induction of autoantibody responses following immunization with cytomegalovirus (CMV) glycoprotein B (gB) in healthy CMV-seronegative subjects. Vaccine. 2004 Dec 16; 23(5):687-92.
    View in: PubMed
    Score: 0.003
  39. Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther. 2005; 7(1):R30-7.
    View in: PubMed
    Score: 0.003
  40. Health of children with chronic arthritis: relationship of different measures and the quality of parent proxy reporting. Arthritis Rheum. 2004 Oct 15; 51(5):763-73.
    View in: PubMed
    Score: 0.003
  41. Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale. Arthritis Rheum. 2004 Jun 15; 51(3):365-70.
    View in: PubMed
    Score: 0.003
  42. Brief report: child-rearing practices of caregivers with and without a child with juvenile rheumatoid arthritis: perspectives of caregivers and professionals. J Pediatr Psychol. 2003 Jun; 28(4):275-9.
    View in: PubMed
    Score: 0.003
  43. Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome. J Pediatr. 2003 Mar; 142(3):292-6.
    View in: PubMed
    Score: 0.003
  44. Comparing parental distress, family functioning, and the role of social support for caregivers with and without a child with juvenile rheumatoid arthritis. J Pediatr Psychol. 2003 Jan-Feb; 28(1):5-15.
    View in: PubMed
    Score: 0.003
  45. A controlled longitudinal study of the social functioning of children with juvenile rheumatoid arthritis. J Pediatr Psychol. 2003 Jan-Feb; 28(1):17-28.
    View in: PubMed
    Score: 0.003
  46. Arthritis in childhood. J Indiana State Med Assoc. 1981 Sep; 74(9):559-64.
    View in: PubMed
    Score: 0.003
  47. Chemokine receptor CCR4 on CD4+ T cells in juvenile rheumatoid arthritis synovial fluid defines a subset of cells with increased IL-4:IFN-gamma mRNA ratios. J Immunol. 2001 Jun 01; 166(11):6899-906.
    View in: PubMed
    Score: 0.003
  48. Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. J Rheumatol. 2001 May; 28(5):1106-11.
    View in: PubMed
    Score: 0.002
  49. Age-specific effects of juvenile rheumatoid arthritis-associated HLA alleles. Arthritis Rheum. 1999 Sep; 42(9):1843-53.
    View in: PubMed
    Score: 0.002
  50. An adolescent with nephrotic syndrome and multiple leg nodules. Pediatr Infect Dis J. 1998 Nov; 17(11):1057-8, 1061-3.
    View in: PubMed
    Score: 0.002
  51. Substance use among adolescents with juvenile rheumatoid arthritis. Arthritis Care Res. 1998 Oct; 11(5):391-6.
    View in: PubMed
    Score: 0.002
  52. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. J Rheumatol. 1998 Jul; 25(7):1388-98.
    View in: PubMed
    Score: 0.002
  53. Parry-Romberg syndrome: follow-up imaging during suppressive therapy. Neuroradiology. 1997 Dec; 39(12):873-6.
    View in: PubMed
    Score: 0.002
  54. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. J Rheumatol. 1996 Dec; 23(12):2116-24.
    View in: PubMed
    Score: 0.002
  55. Long term follow-up of children with mixed connective tissue disease. Lupus. 1996 Jun; 5(3):221-6.
    View in: PubMed
    Score: 0.002
  56. Intravenous immunoglobulin in the treatment of systemic juvenile rheumatoid arthritis: a randomized placebo controlled trial. Pediatric Rheumatology Collaborative Study Group. J Rheumatol. 1994 Dec; 21(12):2353-8.
    View in: PubMed
    Score: 0.002
  57. The iridocyclitis of early onset pauciarticular juvenile rheumatoid arthritis: outcome in immunogenetically characterized patients. J Rheumatol. 1992 Jan; 19(1):160-3.
    View in: PubMed
    Score: 0.001
  58. Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. J Rheumatol. 1991 Sep; 18(9):1394-7.
    View in: PubMed
    Score: 0.001
  59. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. J Pediatr. 1990 Oct; 117(4):645-52.
    View in: PubMed
    Score: 0.001
  60. Proliferative response of peripheral blood mononuclear cells to autologous and allogeneic muscle in patients with polymyositis/dermatomyositis. Arthritis Rheum. 1989 Apr; 32(4):446-53.
    View in: PubMed
    Score: 0.001
  61. Magnetic resonance evaluation of disease of the soft tissues in children. Pediatrics. 1987 May; 79(5):696-701.
    View in: PubMed
    Score: 0.001
  62. School problems and teacher responsibilities in juvenile rheumatoid arthritis. J Sch Health. 1987 May; 57(5):186-90.
    View in: PubMed
    Score: 0.001
  63. Chemotherapy-associated Raynaud's phenomenon in a two-year-old girl. Med Pediatr Oncol. 1985; 13(6):392-4.
    View in: PubMed
    Score: 0.001
  64. Methylprednisolone pulse therapy for nonrenal lupus erythematosus. Ann Rheum Dis. 1980 Aug; 39(4):377-80.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.